News
Zacks.com on MSN17h
DTIL Gets FDA's Fast Track Tag for Hepatitis B Gene Therapy, Stock UpPrecision BioSciences stock soars 24% as the FDA grants the Fast Track designation to its PBGENE-HBV gene therapy for potentially curing chronic hepatitis B.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback